Secondary Logo

Journal Logo

Institutional members access full text with Ovid®

Human Bocavirus Infection in Children With Respiratory Tract Disease

Brieu, Nathalie MSc*; Guyon, Gaël MD; Rodière, Michel MD; Segondy, Michel PhD*; Foulongne, Vincent PhD*

The Pediatric Infectious Disease Journal: November 2008 - Volume 27 - Issue 11 - p 969-973
doi: 10.1097/INF.0b013e31817acfaa
Original Studies

Background: Human bocavirus (HBoV) is a ubiquitous, newly described member of the Parvoviridae family frequently detected in the respiratory tract of children, but only few reports provide data proving the link between HBoV and respiratory tract disease (RTD).

Objectives: To evaluate the incidence of HBoV infection in children with RTD; to analyze the clinical features of HBoV infection; and to clinically compare HBoV, respiratory syncytial virus (RSV), and human metapneumovirus (HMPV) infections.

Study Design: A prospective 1-year study was conducted in children <5 years of age hospitalized with RTD and in asymptomatic control children.

Results: Human bocavirus was detected in 55 (10.8%) of the 507 children tested and in none of the 68 asymptomatic control children (P = 0.01). About 80% of these infections occurred between November and March. Coinfection with another virus was observed in 22 (40%) of the HBoV-positive children. HBoV viral load was significantly higher in samples from children with HBoV monoinfection than in those with coinfection. Subsequent detection of HBoV more than 2 months after the initial detection could be documented in 3 children. Clinical features associated with HBoV infection were similar to those observed with either RSV or HMPV infections, but HBoV infections were less severe than RSV infections.

Conclusions: The difference observed in HBoV prevalence between children with RTD and controls provides support for a role of this virus in RTD. The frequent associations of HBoV with other respiratory viruses might be explained by the persistence of HBoV in the respiratory tract. The significance of HBoV viral load in nasopharyngeal secretions as a marker of pathogenicity merits further investigation.

From the Departments of *Virology and †Pediatrics, Montpellier University Hospital, Montpellier Cedex, France.

Accepted for publication April 8, 2008.

Address for correspondence: Vincent Foulongne, PhD, Laboratory of Virology, Hôpital St-Eloi, 34295 Montpellier Cedex 05, France. E-mail:

Supplemental Digital Content is available for this article. Direct URL citations appear in the printed text; simply type the URL address into any Web broswer to access this content. Clickable links to the material are provided in the HTML text and PDF of this article on the Journal's Web site (

© 2008 Lippincott Williams & Wilkins, Inc.